ATE447858T1 - Pharmazeutische zusammensetzung für muskelanabolismus - Google Patents

Pharmazeutische zusammensetzung für muskelanabolismus

Info

Publication number
ATE447858T1
ATE447858T1 AT01910231T AT01910231T ATE447858T1 AT E447858 T1 ATE447858 T1 AT E447858T1 AT 01910231 T AT01910231 T AT 01910231T AT 01910231 T AT01910231 T AT 01910231T AT E447858 T1 ATE447858 T1 AT E447858T1
Authority
AT
Austria
Prior art keywords
anabolic
pharmaceutical composition
initiators
denatured
muscle anabolism
Prior art date
Application number
AT01910231T
Other languages
English (en)
Inventor
Rudolf Smeets
Robert Hageman
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23990994&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE447858(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of ATE447858T1 publication Critical patent/ATE447858T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/832—Milk; colostrum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/833—Whey; cheese

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01910231T 2000-02-10 2001-02-12 Pharmazeutische zusammensetzung für muskelanabolismus ATE447858T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/500,802 US6521591B1 (en) 2000-02-10 2000-02-10 Pharmaceutical composition for muscular anabolism
PCT/NL2001/000112 WO2001058284A1 (en) 2000-02-10 2001-02-12 Pharmaceutical composition for muscular anabolism

Publications (1)

Publication Number Publication Date
ATE447858T1 true ATE447858T1 (de) 2009-11-15

Family

ID=23990994

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01910231T ATE447858T1 (de) 2000-02-10 2001-02-12 Pharmazeutische zusammensetzung für muskelanabolismus

Country Status (9)

Country Link
US (1) US6521591B1 (de)
EP (1) EP1253830B1 (de)
AT (1) ATE447858T1 (de)
AU (2) AU2001237809B2 (de)
CA (1) CA2398990C (de)
DE (1) DE60140426D1 (de)
ES (1) ES2336764T3 (de)
HK (1) HK1048050B (de)
WO (1) WO2001058284A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
US7744930B2 (en) * 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
US20050143343A1 (en) * 2003-12-30 2005-06-30 Nerenberg Arnold P. Nutritional supplement for enhancing the production and effect of natural human growth hormone
US7799817B2 (en) * 2004-02-20 2010-09-21 Lifescape Biosciences Inc Compositions and methods for sleep regulation
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
US20060013889A1 (en) * 2004-07-16 2006-01-19 Playford Raymond J Colostrum-based treatment for irritable bowel syndrome
US20060045906A1 (en) * 2004-08-25 2006-03-02 Gardiner Paul T Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle
US7426440B2 (en) * 2004-09-24 2008-09-16 Nutritional Bioscience Ltd. Repair and protection factor scoring method for bioactive agents
US20060068022A1 (en) * 2004-09-29 2006-03-30 Playford Raymond J Bioactive agent compositions for repair of cell injuries
CA2537647A1 (en) * 2005-03-01 2006-09-01 Six Star Formulations Ltd. Supplemental dietary composition for supporting muscle growth, recovery and strength
DE102005028446A1 (de) * 2005-06-17 2006-12-28 Sibylle E. Bauer Zusammensetzung, insbesondere Nahrungsergänzungsmittel
EP1973426A2 (de) * 2005-11-03 2008-10-01 Southwest Immunology Inc. Zusammensetzungen für die vorbeugung und linderung von muskelkater
NZ568611A (en) 2005-12-19 2011-11-25 Abbott Lab Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type 1 and type 2 cytokine production
CN101524155B (zh) * 2009-04-20 2012-10-10 北京康比特体育科技股份有限公司 一种氨基酸组合物
CN106937742A (zh) * 2010-01-29 2017-07-11 雅培制药有限公司 包含喷雾干燥的hmb的营养粉
CA2785522C (en) * 2010-01-29 2015-09-29 Abbott Laboratories Nutritional emulsions comprising calcium hmb and soluble protein
EP2461704B1 (de) 2010-01-29 2013-10-09 Abbott Laboratories Aseptisch verpackte nahrungsflüssigkeiten mit hmb
WO2011094557A1 (en) 2010-01-29 2011-08-04 Abbott Laboratories Nutritional emulsions comprising calcium hmb
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
CN101791127B (zh) * 2010-03-05 2012-07-18 北京康比特体育科技股份有限公司 一种含有HMβ的肌肉保护组合物
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
ES2633360T3 (es) 2014-04-02 2017-09-20 Alzchem Ag Matriz de creatina y proteínas así como procedimiento para la producción de esta matriz
US11865121B2 (en) 2016-02-11 2024-01-09 Nutrition21, LLC Chromium containing compositions for improving health and fitness
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
EP3668499A1 (de) 2017-08-14 2020-06-24 Axcella Health Inc. Aminosäurezusammensetzungen zur behandlung von lebererkrankungen
WO2019246225A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
TWI737987B (zh) * 2019-04-23 2021-09-01 豐華生物科技股份有限公司 一種乳酸菌菌株在製備提升運動能力與抗疲勞之組合物之用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036052A (en) * 1988-06-22 1991-07-30 Morishita Pharmaceutical Co., Ltd. Amino acid nutrient compositions
US5726146A (en) * 1994-12-06 1998-03-10 Natural Supplement Association, Incorporated Non-steroidal, anabolic dietary supplement and method to increase lean mass without linked increase fat mass
BR9808088A (pt) 1997-03-27 2000-03-08 Michael J Sole Suplemento nutricional, uso do mesmo e métodos de tratamento de um sistema orgânico crìtico e de insuficiência cardìaca congestiva
EP0875155A1 (de) 1997-05-01 1998-11-04 N.V. Nutricia Perioperatives Getränk
AUPP327198A0 (en) * 1998-04-30 1998-05-21 Northfield Laboratories Pty Ltd A food composition and method of using same
DE69930746T2 (de) 1998-06-10 2007-03-15 Crum, Albert B. Vorbeugender und therapeutischer nahrungsmittelzusatz zur schaffung/erhaltung einer die gesundheit schützenden darmmikroflora und zur stärkung des immunsystems

Also Published As

Publication number Publication date
HK1048050A1 (en) 2003-03-21
EP1253830B1 (de) 2009-11-11
AU2001237809B2 (en) 2005-04-07
ES2336764T3 (es) 2010-04-16
EP1253830A1 (de) 2002-11-06
WO2001058284A1 (en) 2001-08-16
AU3780901A (en) 2001-08-20
HK1048050B (en) 2009-12-31
DE60140426D1 (de) 2009-12-24
US6521591B1 (en) 2003-02-18
CA2398990C (en) 2013-04-02
CA2398990A1 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
DE60140426D1 (de) Pharmazeutische zusammensetzung für muskelanabolismus
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
PL370111A1 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
SE0001899D0 (sv) New compounds
DE50015623D1 (de) Kovalent verbrückte insulindimere
IL139227A0 (en) N-substituted aminotetralins as ligands for the neuropeptide yy5 receptor useful in the treatment of obesity and other disorders
BRPI0514420A (pt) peptìdeo, variante do mesmo, ou um sal farmaceuticamente aceitável do mesmo, composição, uso de um peptìdeo ou de uma variante de peptìdeo, substrato, e, métodos de tratamento ou prevenção de um infecção microbiana, e de tratamento de uma ferida em um indivìduo
CY1107146T1 (el) Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
GB0222514D0 (en) Organic compounds
IL164974A0 (en) Novel compounds and their use
NZ547587A (en) Pharmaceutical compositions and methods for insulin treatment
MEP55308A (en) New pharmaceutical compositions containing flibanserin polymorph a
MY134167A (en) Biphenylcarboxamides useful as lipid lowering agents
IT1299583B1 (it) Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
DE60015508T2 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
TW200503666A (en) Treatment of type 1 diabetes with pde5 inhibitors
ITRM20030596A1 (it) Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3.
WO2005056520A8 (en) Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
EP1813289A4 (de) Medizinische zusammensetzung zur behandlung von krebs oder diabetes
EP1260221A3 (de) Kombinationsbehandlung für Depression und Angstzustände
GB0128071D0 (en) Medicament
IL156639A0 (en) Phenethanolamine derivatives, methods for their preparation and pharmaceutical compositions containing them
BR9812869A (pt) Processo para a preparação de benzofuranonas eventualmente substituìdas
SE0202608D0 (sv) New sequences
DE60117472D1 (de) Pharmazeutische zusammensetzung zur behandlung von fettleibigkeit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties